Patents by Inventor Marie-Emmanuelle Riviere

Marie-Emmanuelle Riviere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition of Organic Compounds
    Publication number: 20160101167
    Abstract: The present invention relates to compositions comprising a construct comprising the A?1-6 peptide and a pharmaceutically acceptable adjuvant, for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Applicant: Novartis AG
    Inventors: Peter Ulrich, Katja Baer, Georges Imbert, Marie-Jose Hoellinger, Marie-Emmanuelle Riviere, Ana Graf
  • Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
    Publication number: 20150297692
    Abstract: The present invention relates to compositions comprising a construct comprising the A?1-6 peptide and a pharmaceutically acceptable adjuvant, for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type.
    Type: Application
    Filed: June 26, 2015
    Publication date: October 22, 2015
    Applicant: Novartis AG
    Inventors: Peter Ulrich, Katja Baer, Georges Imbert, Marie-Jose Hoellinger, Marie-Emmanuelle Riviere, Ana Graf
  • Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
    Publication number: 20140348871
    Abstract: The present invention relates to compositions comprising a construct comprising the A?1-6 peptide and a pharmaceutically acceptable adjuvant, for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type.
    Type: Application
    Filed: August 11, 2014
    Publication date: November 27, 2014
    Applicant: Novartis AG
    Inventors: Peter Ulrich, Katja Baer, Georges Imbert, Marie-Jose Hoellinger, Marie-Emmanuelle Riviere, Ana Graf
  • Composition Comprising the Amyloid Beta 1-6 Peptide Coupled to a Virus-Like Particle and an Adjuvant
    Publication number: 20130011431
    Abstract: The present invention relates to compositions comprising a construct comprising the A?1-6 peptide and a pharmaceutically acceptable adjuvant, for the treatment of patients suffering from dementia, in particular dementia of the Alzheimer's type. In one embodiment, the construct containing the A?1-6 peptide consists of a virus-like particle (VLP) of the RNA bacteriophage Q? chemically coupled to said A?1-6 peptide.
    Type: Application
    Filed: March 28, 2011
    Publication date: January 10, 2013
    Applicant: NOVARTIS AG
    Inventors: Peter Ulrich, Katja Baer, Georges Imbert, Marie-Jose Hoellinger, Marie-Emmanuelle Riviere, Ana Graf